Asset Details
Do you wish to reserve the book?
Lymphatic pumping failure in the arm precedes dermal backflow and breast cancer-related lymphedema
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lymphatic pumping failure in the arm precedes dermal backflow and breast cancer-related lymphedema
Do you wish to request the book?
Lymphatic pumping failure in the arm precedes dermal backflow and breast cancer-related lymphedema
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lymphatic pumping failure in the arm precedes dermal backflow and breast cancer-related lymphedema
2026
Overview
Background
Breast cancer patients who undergo regional nodal irradiation therapy (RNI) following neoadjuvant chemotherapy and mastectomy or lumpectomy with axillary lymph node dissection (ALND) frequently encounter breast cancer-related lymphedema (BCRL). Early detection and treatment can significantly improve outcomes. Previously, near-infrared fluorescence lymphatic imaging (NIRF-LI) detection of dermal backflow, or retrograde lymphatic flow into initial lymphatics, was shown to precede clinical BCRL diagnosis by 8–23 months. Herein, we hypothesize that lymphatic pump failure is responsible for dermal backflow and may be a target to prevent onset of BCRL symptoms.
Methods
Arm lymphatics in 51 patients with locally advanced breast cancer were visualized with NIRF-LI in a prospective, longitudinal, observational clinical cohort study. Lymphatic pumping frequencies were measured to investigate pumping changes during and after breast cancer treatment. Lymphatic pumping was quantified at five timepoints: after neoadjuvant chemotherapy, but before breast cancer excision and ALND, again at four weeks post-ALND, and at 6, 12, and 18 months post-RNI. Repeated measures mixed-effects analysis was used to compare the mean pumping frequencies amongst all time points. Additionally, pairwise comparisons between any two time points were performed using Wilcoxon matched-pairs signed rank test.
Results
As time lapsed after surgical treatment and RNI, ipsilateral dorsal forearm, ipsilateral ventral forearm, and ventral axilla pumping failure preceded the appearance of dermal backflow and clinically diagnosed BCRL, suggesting that lymphatic pumping dysfunction is the first step in BCRL development.
Conclusions
This study suggests that impairment of the intrinsic lymph pump may be responsible for the onset of clinical BCRL symptoms, and therefore represents a target for prevention of cancer-acquired lymphedema. Future research is needed to understand the molecular determinants of the intrinsic lymphatic pump, and how cancer treatments and interventions can impact them.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Adult
/ Aged
/ Biomedical and Life Sciences
/ Breast Cancer Lymphedema - diagnosis
/ Breast Cancer Lymphedema - etiology
/ Breast Cancer Lymphedema - physiopathology
/ Breast cancer-related lymphedema
/ Breast Neoplasms - complications
/ Breast Neoplasms - pathology
/ Cancer
/ Female
/ Females
/ Forearm
/ Humans
/ Lymph Node Excision - adverse effects
/ Lymphatic Vessels - physiopathology
/ Mastectomy - adverse effects
/ Near-infrared fluorescence lymphatic imaging
/ Neoadjuvant Therapy - adverse effects
/ Oncology
/ Patients
